You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 15, April 15, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Colon Cancer
 •Ovarian Cancer
 •Oncology, Other
 •Statistics and Research Methods
 •Endocrine Diseases
 •Diabetes Mellitus
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Long-term Mortality in Cancer Patients With Preexisting Diabetes—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: In response to Drs van de Poll-Franse and Coebergh, we agree that the weight assigned to the risk estimate from the study by Kouvaris et al1 seems surprisingly large given its modest sample size. However, the weight reflects the narrow CI the article reported for diabetes and mortality in the unadjusted Cox model (HR, 1.038; 95% CI, 1.006-1.099). Such narrow CIs reflect the kind of precision typically attained in much larger studies. We did not request the data required to double-check precision estimates as part of our protocol. However, we are certain that the study by Kouvaris et al did not unduly influence our overall pooled results, since exclusion of that study in our influence analysis produced a robust estimate of long-term mortality risk related to preexisting diabetes (HR, 1.43; 95% CI, 1.32-1.55).

The discussion of the study by van de Poll-Franse et al2 is most helpful. We . . . [Full Text of this Article]

Bethany B. Barone, ScM
Department of Epidemiology

Hsin-Chieh Yeh, PhD; Frederick L. Brancati, MD, MHS
fbrancat@jhmi.edu
Department of Medicine
Johns Hopkins University
Baltimore, Maryland



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus: A Systematic Review and Meta-analysis
Bethany B. Barone, Hsin-Chieh Yeh, Claire F. Snyder, Kimberly S. Peairs, Kelly B. Stein, Rachel L. Derr, Antonio C. Wolff, and Frederick L. Brancati
JAMA. 2008;300(23):2754-2764.
ABSTRACT | FULL TEXT  

RELATED LETTER

Long-term Mortality in Cancer Patients With Preexisting Diabetes
Lonneke van de Poll-Franse and Jan Willem Coebergh
JAMA. 2009;301(15):1541.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.